Afatinib in the first-line treatment of epidermal-growth-factor-receptor mutation-positive non-small cell lung cancer: a review of the clinical evidence

door E-E Ke, Yi-Long Wu
Gepubliceerd in 2016-06-01

Intratumoral genetic and immune microenvironmental heterogeneity in T4N0M0 (diameter ≥ 7 cm) non‐small cell lung cancers

door Jia−Tao Zhang, Song Dong, Li−Yan Ji, Jia−Ying Zhou, Zhi− Hong Chen, Jian Su, Qing−Ge Zhu, Meng−Min Wang, E−E. Ke, Hao Sun, Xue−Tao Li, Jin−Ji Yang, Qing Zhou, Xu− Chao Zhang, Xuan Gao, Xue−Ning Yang, Xuefeng Xia, Xin Yi, Wen−Zhao Zhong, Yi−Long Wu
Gepubliceerd in 2022-05-01